Cadila Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CADILA, and what generic and branded alternatives to CADILA drugs are available?
CADILA has forty-one approved drugs.
Summary for Cadila
US Patents: | 0 |
Tradenames: | 35 |
Ingredients: | 35 |
NDAs: | 41 |
Patent Litigation for Cadila: | See patent lawsuits for Cadila |
Drugs and US Patents for Cadila
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cadila | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 210188-002 | Aug 19, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila Pharms Ltd | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | CAPSULE;ORAL | 206993-001 | May 23, 2019 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila Pharms Ltd | FOLIC ACID | folic acid | TABLET;ORAL | 202437-001 | Jan 27, 2014 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila Pharms Ltd | ERYTHROMYCIN | erythromycin | TABLET;ORAL | 213628-001 | Jun 28, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila Pharms Ltd | RIVASTIGMINE TARTRATE | rivastigmine tartrate | CAPSULE;ORAL | 203844-004 | Feb 13, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila | METRONIDAZOLE | metronidazole | TABLET;ORAL | 206560-001 | Nov 16, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | bisoprolol fumarate; hydrochlorothiazide | TABLET;ORAL | 215666-002 | Nov 4, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.